Development of a multi-functional biopolymer scaffold for neural tissue engineering

Spinal cord injury (SCI) affects approximately 270,000 people in the U.S., with approximately 12,000 new cases occurring every year. Several strategies have been investigated to enhance axonal regeneration after SCI, however, the resulting growth can be random and disorganized. Bioengineered scaffolds provide a physical substrate for the guidance of regenerating axons towards their targets, and can be produced by freeze casting. This technique involves the controlled directional solidification of an aqueous solution or suspension, resulting in a linearly aligned porous structure caused by ice templating. In this thesis, freeze casting was used to create novel porous chitosan-alginate (C/A) scaffolds with longitudinally aligned channels and a compressive modulus (5.08 ± 0.61 kPa) comparable to that of native spinal cord tissue. These C/A scaffolds supported the viability, attachment, and directionally oriented growth of chick dorsal root ganglia (DRG) neurites in vitro, with surface adsorptions of polycations and laminin promoting significantly longer neurite growth than the uncoated scaffolds (p<0.001). In order to integrate therapeutic biomolecules within the scaffolds for sustained release, alginate and chitosan microcapsules produced by spray drying were used to encapsulate brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3), and the enzyme chondroitinase ABC (chABC) prior to scaffold incorporation. BDNF and NT-3 were released from the C/A scaffolds in a sustained manner for 8 weeks in vitro, while chABC was released for up to 35 days. However, up to 85% of biomolecules remained entrapped within the scaffold walls, due to limitation of diffusion by the scaffold wall mesh size. Release of bioactive chABC and neurotrophins from the multi-functional scaffolds promoted the growth of DRG neurites through an in vitro barrier of chondroitin sulfate proteoglycans, a main inhibitory component of the growth-inhibiting glial scar in the injured spinal cord. The present data suggest these multi-functional scaffolds are suitable for use and future testing in vivo as a combination strategy for spinal cord repair due to their ability to promote the directionally oriented growth of neurites and their ability to provide the sustained release of therapeutic bioactive molecules for the stimulation of axonal growth through the glial scar.